Neuphoria Therapeutics Inc. (NEUP) Return on equity 2025–2026
Neuphoria Therapeutics Inc. (NEUP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-54.7%FY2026 · since FY2025: -1.9% → -54.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -54.7% | -52.7 pp |
| FY2025 | -1.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice